Kyntra Bio (KYNB) EBITDA Margin (QoQ) (2014 - 2026)
Kyntra Bio (KYNB) EBITDA Margin (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.65 Bn | 130.80 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.94 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.84 Bn | 59.66 Bn | 1.37 Bn |
| 4 | Moderna | 57.38 Bn | 52.25 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.72 Bn | 9.33 Bn | 668.28 Mn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Kyntra Bio | 30.56 Mn | 30.56 Mn | 1.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -77,354.00 |
| Mar 31, 2026 | 68,844.00 |
| Dec 31, 2025 | -55,522.00 |
| Sep 30, 2025 | 39,118.00 |
| Jun 30, 2025 | -34,934.00 |
| Mar 31, 2025 | -31,720.00 |
| Dec 31, 2024 | 3.85 Mn |
| Sep 30, 2024 | -2.72 Mn |
| Jun 30, 2024 | -936,645.00 |
| Mar 31, 2024 | -236,439.00 |
| Dec 31, 2023 | 28,702.00 |
| Sep 30, 2023 | 45,327.00 |
| Jun 30, 2023 | 386,450.00 |
| Mar 31, 2023 | -368,842.00 |
| Dec 31, 2022 | -19,231.00 |
| Sep 30, 2022 | -33,277.00 |
| Jun 30, 2022 | 38,034.00 |
| Mar 31, 2022 | 17,473.00 |
| Dec 31, 2021 | -85,019.00 |
| Sep 30, 2021 | 58,200.00 |